Results 11 to 20 of about 96,136 (196)

Impact of Beta‐Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population‐Based Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRelevant clinical studies have been small and have not convincingly demonstrated whether the perioperative initiation of beta‐blockers should be considered in patients with diabetes mellitus undergoing noncardiac surgery.
Ray‐Jade Chen, Hsi Chu, Lung‐Wen Tsai   +2 more
doaj   +1 more source

Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression. [PDF]

PLoS ONE, 2018
Stroke-induced immunodepression is a well characterized complication of acute ischemic stroke. In experimental studies beta-blocker therapy reversed stroke-induced immunodepression, reduced infection rates and mortality.
Ilko L Maier, Johannes C Becker, Johanna Rosemarie Leyhe, Marlena Schnieder, Daniel Behme, Marios-Nikos Psychogios, Jan Liman   +6 more
doaj   +1 more source

Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients

Cardiovascular Diabetology, 2019
Background Although beta blockers could increase the risk of hypoglycemia, the difference between subtypes on hypoglycemia and mortality have not been studied.
Kathleen Dungan, Jennifer Merrill, Clarine Long, Philip Binkley   +3 more
doaj   +1 more source

Evaluation of central: peripheral blood pressure ratio in patients undergoing coronary angiography: A pilot study from North India

Heart India, 2020
Aim: The study aimed to propose the ratio of central blood pressure:peripheral blood pressure as a novel index to predict cardiovascular risk. We additionally attempted to determine the impact of beta-blocker therapy on this ratio. Materials and Methods:
Sharad Chandra, Gaurav Chaudhary, Varun Shankar Narain, Sudhanshu Kumar Dwivedi, Akhil Sharma   +4 more
doaj   +1 more source

An Update on the Use of Molecularly Imprinted Polymers in Beta-Blocker Drug Analysis as a Selective Separation Method in Biological and Environmental Analysis

Molecules, 2022
Beta-blockers are antihypertensive drugs and can be abused by athletes in some sport competitions; it is therefore necessary to monitor beta-blocker levels in biological samples.
Aliya Nur Hasanah, Ike Susanti, Mutakin Mutakin   +2 more
doaj   +1 more source

Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. [PDF]

PLoS ONE, 2015
BACKGROUND:Infections are a frequent cause for prolonged hospitalization and increased mortality after stroke. Recent studies revealed a stroke-induced depression of the peripheral immune system associated with an increased susceptibility for infections.
Ilko L Maier, André Karch, Rafael Mikolajczyk, Mathias Bähr, Jan Liman   +4 more
doaj   +1 more source

PENGARUH PENGGUNAAN BETA BLOCKER TOPIKAL JANGKA PANJANG TERHADAP SENSIBILITAS KORNEA PADA PASIEN GLAUKOMA

Jurnal Kedokteran Diponegoro, 2017
Latar Belakang : Penurunan sensibilitas kornea merupakan salah satu efek samping dari penggunaan beta blocker topikal yang dapat menimbulkan berbagai masalah seperti penurunan reflex mengedip, penurunan kemampuan penyembuhan luka pada kornea, dan terkait
Tusita Devi, Fifin Luthfia Rahmi
doaj   +1 more source

Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis

Clinical Medicine Insights: Endocrinology and Diabetes, 2022
Background: Depression is associated with lower quality of life and increased risk of mortality. The prevalence of depression in chronic dialysis patients, as well as in patients with diabetes, is more than 20%. It is debated whether use of beta-blockers
Robin Lengton, Robbert W Schouten, Els Nadort, Elisabeth FC van Rossum, Friedo W Dekker, Carl EH Siegert, Ellen K Hoogeveen   +6 more
doaj   +1 more source

Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey

ESC Heart Failure, 2021
Aims The use of beta‐blocker therapy in cardiac amyloidosis (CA) is debated. We aimed at describing patterns of beta‐blocker prescription through a nationwide survey.
Giacomo Tini, Francesco Cappelli, Elena Biagini, Beatrice Musumeci, Marco Merlo, Lia Crotti, Matteo Cameli, Gianluca Di Bella, Alberto Cipriani, Francesca Marzo, Federico Guerra, Cinzia Forleo, Christian Gagliardi, Mattia Zampieri, Samuela Carigi, Pier Filippo Vianello, Giulia Elena Mandoli, Giuseppe Ciliberti, Luca Lichelli, Davide Mariani, Aldostefano Porcari, Domitilla Russo, Roberto Licordari, Alberto Ponziani, Italo Porto, Federico Perfetto, Camillo Autore, Claudio Rapezzi, Giafranco Sinagra, Marco Canepa   +29 more
doaj   +1 more source

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

Journal of Ophthalmology, 2017
Objective. To evaluate the efficacy and tolerability of travoprost 0.004%/timolol 0.5% fixed-dose combination (TTFC) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) inadequately controlled on beta-blocker monotherapy. Methods.
Simon Fabian Lerner, Ki Ho Park, Douglas A. Hubatsch, Valeriy Erichev, Jose A. Paczka, Timothy V. Roberts   +5 more
doaj   +1 more source